Abvc Biopharma (ABVC) Construction in Progress (2023 - 2025)

Abvc Biopharma (ABVC) has reported Construction in Progress for 3 consecutive years, with $7.4 million the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Construction in Progress changed N/A year-over-year to $7.4 million; the trailing twelve-month figure through Sep 2025 stood at $7.4 million (changed N/A YoY), and the FY2024 full-year result was $7.4 million, up 1199.89% from the prior year.
• Construction in Progress steadied at $7.4 million in Q3 2025 per ABVC's latest filing, from $7.4 million in the prior quarter.
• Across five years, Construction in Progress topped out at $7.4 million in Q4 2024 and bottomed at $529121.0 in Q2 2024.
• Historically, Construction in Progress has averaged $4.5 million across 3 years, with a median of $7.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Construction in Progress surged 1199.89% in 2024, then soared 1298.55% in 2025.
• Over 3 years, Construction in Progress stood at $569278.0 in 2023, then soared by 1199.89% to $7.4 million in 2024, then changed by 0.0% to $7.4 million in 2025.
• According to Business Quant data, Construction in Progress over the past three periods registered $7.4 million, $7.4 million, and $7.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.